The number and complexity of available lab tests has increased rapidly in recent years, making it difficult for clinicians to stay on top of the best, most appropriate tests to order. This can lead to ...
Diagnostic test developers, including clinical laboratories, responded to the COVID-19 pandemic with inspiring creativity to meet patient testing needs. These developers found unique ways to enable ...
The cash sum is what IQVIA paid to acquire Quest’s minority stake in the business, called Q2 Solutions. In 2015, IQVIA and Quest combined the global clinical trial laboratory operations of their ...